Finance

Lists
Why is ONCO up 2,52%?
Dive Deeper
ONCO:STO
Oncopeptides AB
1,79 SEK
+2,52%
(+0,044) 1D
16 ოქტ, 16:06:34 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ONCO...
Open
1,76 SEK
High
1,86 SEK
Low
1,74 SEK
Mkt. cap
684,19 მლნ.
Avg. vol.
7,36 მლნ.
Volume
4,67 მლნ.
52-wk high
5,79 SEK
52-wk low
1,25 SEK
EPS
-0,77 SEK
Shares outstanding
381,36 მლნ.
No. of employees
69
Open
1,76 SEK
High
1,86 SEK
Low
1,74 SEK
Mkt. cap
684,19 მლნ.
Avg. vol.
7,36 მლნ.
Volume
4,67 მლნ.
52-wk high
5,79 SEK
52-wk low
1,25 SEK
EPS
-0,77 SEK
Shares outstanding
381,36 მლნ.
No. of employees
69
News stories
From web sources and news partners
About Oncopeptides AB
CEO-
Employees69
Founded2000
Headquarters-
Sector-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
20,21 მლნ.
18,57 მლნ.
25,38 მლნ.
31,10 მლნ.
Cost of goods sold
288,00 ათ.
1,85 მლნ.
320,00 ათ.
966,00 ათ.
Cost of revenue
288,00 ათ.
1,85 მლნ.
320,00 ათ.
966,00 ათ.
Research and development expenses
17,29 მლნ.
35,90 მლნ.
21,49 მლნ.
23,53 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
50,91 მლნ.
43,19 მლნ.
44,27 მლნ.
57,56 მლნ.
Operating expense
66,98 მლნ.
79,23 მლნ.
62,60 მლნ.
78,80 მლნ.
Total operating expenses
67,27 მლნ.
81,08 მლნ.
62,92 მლნ.
79,77 მლნ.
Operating income
-47,05 მლნ.
-62,52 მლნ.
-37,53 მლნ.
-48,67 მლნ.
Other non operating income
-1,00 ათ.
-12,33 მლნ.
1,00 ათ.
-
EBT including unusual items
-60,76 მლნ.
-63,99 მლნ.
-32,06 მლნ.
-54,60 მლნ.
EBT excluding unusual items
-60,76 მლნ.
-63,28 მლნ.
-32,06 მლნ.
-54,60 მლნ.
Income tax expense
139,00 ათ.
1,18 მლნ.
123,00 ათ.
108,00 ათ.
Effective tax rate
-0,23%
-1,85%
-0,38%
-0,20%
Other operating expenses
-1,22 მლნ.
139,00 ათ.
-3,17 მლნ.
-2,29 მლნ.
Net income
-60,89 მლნ.
-65,17 მლნ.
-32,18 მლნ.
-54,71 მლნ.
Net profit margin
-301,25%
-351,02%
-126,79%
-175,93%
Earnings per share
-
-
-
-
Interest and investment income
-
8,55 მლნ.
5,47 მლნ.
-
Interest expense
-13,70 მლნ.
-
-
-5,94 მლნ.
Net interest expenses
-13,70 მლნ.
8,55 მლნ.
5,47 მლნ.
-5,94 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-46,43 მლნ.
-61,95 მლნ.
-36,96 მლნ.
-48,10 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები